SEC Form 4 · accession 0001127602-15-017039
ARRAY BIOPHARMA INC · ARRY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles M Baum
Director
Period of report
May 8, 2015
Accepted (ET)
May 12, 2015 · 8:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100412
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 8, 2015 | M | 25,000 | $3.86 | A | 25,000 | D | |
| Common StockF1 | May 8, 2015 | S | 25,000 | $7.3793 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $3.86 | May 8, 2015 | M | 25,000 | D | Apr 24, 2015 | Apr 25, 2024 | Common Stock | 25,000 | 0 | D |
Explanation of responses
- F1The price reported for these shares is the weighted average sale price. Details of actual prices for shares sold are available from the Issuer upon request.